A Multicenter Randomized Controlled Trial of Nevirapine Versus a Combination of Zidovudine and Lamivudine to Reduce Intrapartum and Early Postpartum Mother‐to‐Child Transmission of Human Immunodeficiency Virus Type 1
Dhayendre Moodley(Centre for the AIDS Programme of Research in South Africa), Maria Gigliotti(Boehringer Ingelheim (Germany)), James McIntyre(Perinatal HIV Research Unit), Patrick Robinson(Boehringer Ingelheim (Germany)), Lynette Boshoff(Mintek), Justus Hofmyer, Jagidesa Moodley(University of KwaZulu-Natal), David B. Hall(Boehringer Ingelheim (Germany)), John L. Sullivan, Hoosen Coovadia(University of KwaZulu-Natal), Glenda Gray(South African Medical Research Council), Cheryl Nikodem
Cited by 346
Related Papers
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
|New England Journal of Medicine|2021|2.6k
Gender-based violence, relationship power, and risk of HIV infection in women attending antenatal clinics in South Africa
|The Lancet|2004|1.3k
T cell responses to SARS-CoV-2 spike cross-recognize Omicron
|Nature|2022|623
Transactional sex among women in Soweto, South Africa: prevalence, risk factors and association with HIV infection
|Social Science & Medicine|2004|573
Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition
|New England Journal of Medicine|2021|540